Company / Current Assets
MBX Biosciences, Inc. Current Assets History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$267.3M
FY2024
5-year range
$83.5M / $267.3M
FY2023-FY2024
Trend
+220.2%
vs FY2023
Sector context
#175 of 213
Health Care
What the data says
MBX Biosciences, Inc.'s current assets of $267M is lower than 82% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
$267M in FY2024.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 213This company $267.3M Sector average $2.5B
▼
-89.4% below sector average
Key checks
Key Insights
- In FY2024, current assets increased 220.2% year-over-year.
- Ranks #175 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $267.3M | +220.2% |
| FY2023 | $83.5M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026